Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: Effect on different tests for INR determination

Journal of Thrombosis and Thrombolysis

Volumn 9, Issue 3, 2000, Pages 263-269

  Bijsterveld, Nick R ^a,b   Middeldorp, Saskia ^a   Berends, Fenny ^a   Büller, Harry R ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Antiphospholipid antibodies; INR; Lupus anticoagulant; Warfarin

Indexed keywords

ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; LUPUS ANTICOAGULANT; REAGENT; WARFARIN;

ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; LABORATORY TEST; PRIORITY JOURNAL; THROMBOSIS;

EID: 0034112769     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018722829498     Document Type: Article

References (29)

1. Long AA, Ginsberg JS, Brill-Edwards, et al. The relationship of antiphospholipid antibodies to thromboembolic diseases in systemic lupus erythematoses: A cross-sectional study. Thromb Haemost 1991;66:520-624.
2. Pauzner R, Rosner E, Many A. Circulating anticoagulant in systemic lupus erythematosus: Clinical manifestations. Acta Haematol 1986;76:90-94.
3. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other "antiphospholipid" antibodies. Blood 1994;84:2854-2867.
4. Simioni P, Prandoni P, Zanon E, et al. Deep venous thrombosis and lupus anticoagulant. Thromb Haemost 1996;76(2): 187-189.
5. Ginsberg JS, Wells PS, Brill-Edwards P, et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995; 86:3685-3691.
6. Moll S, Ortel TM. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann Intern Med 1997;127:177-185.
7. Della Valle P, Drippa L, D'Angelo A. Potential failure of the International Normalized Ratio (INR) system in monitoring of oral anticoagulation in patients with lupus anticoagulants. Ann de Med Int 1996;147(Suppl 1):10-14.
8. Low J, Joseph J, Concannon A. INR discrepancies with a recombinant thromboplastin in two patients with the antiphospholipid syndrome. Thromb Haemost 1997;78(S):701.
9. Lawrie AS, Purdy G, Mackie IJ, Machin SJ. Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the antiphospholipid syndrome. Br J Haematol 1997;98:887-892.
10. Robert A, Le Querrec A, Delahousse B, et al. Control of oral anticoagulation in patients with the antiphopholipid syndrome - Influence of the lupus anticoagulant on International Normalized Ratio. Thromb Haemost 1998;80:99-103.
11. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992;117:303-308.
12. Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-997.
13. Prandoni P, Simioni P, Girolami A. Antiphospholipid antibodies, recurrent thromboembolism, and intensity of warfarin anticoagulation. Thromb Haemost 1996;75:859-863.
14. Derksen RHWM, de Groot Ph G. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 1993; 52:689-692.
15. Rivier G, Teresa Herranz M, Munther A, Khamashta, Hughes GRV. Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments. Lupus 1994;3:85-90.
16. Nojima J, Suehisa E, Akita N, et al. Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulant. Br J Haem 1997;96:447-450.
17. Finazzi G, Brancaccio V, Moia M, et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the Italian registry. Am J Med 1996:100;530-536.
18. Nasr SZ. [Letter] Thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995;333(10):666.
19. Violi F. [Letter] Thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995;333(10):665.
20. Slivka A. [Letter] Thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995;333(10):665.
21. Khamashta MA. [Letter] Thrombosis in the antiphospholipid antibody syndrome. N Engl JMed 1995;333(10):667.
22. Lockshin MD. [Letter] Thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995;333(10):667.
23. Finazzi G, Barbui T, for the International Steering Committee of the WAPS study. Proposal of clinical trial of high dose warfarin in the antiphospholipid syndrome: The WAPS' study. Lupus 1996;5:556.
24. Brandt JT, Triplett DA, Alving B, Scharrer I, on behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Criteria for the diagnosis of lupus anticoagulants: An update. Thromb Haemost 1995;74:1185-1190.
25. Ciavarella N, Coccheri S, Gensini GF, et al. Multicenter evaluation of a new chromogenic Factor X assay in plasma of patients on oral anticoagulants. Thromb Res 1980;19:493-502.
26. Hirsh J, Dalen JE, Deykin D, Poller L, Bussey H. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1995;108(Suppl):231S-246S.
27. Dzung TL, Weibert RT, Barbara K, et al. The International Normalized Ratio (INR) for monitoring warfarin therapy: Reliability and relation to other monitoring methods. Ann Int Med 1994;120:552-558.
28. Aurell L, Friberger P, Karlsson G, Claeson G. A new sensitive and highly specific chromogenic peptide substrate for factor Xa. Thromb Res 1977;11:595-609.
29. van Wijk, EM, Kahle LH, ten Cate JW. Mechanised amidolytic technique for determination of factor X and factor X-antigen, and its applications to patients being treated with oral anticoagulants. Clin Chem 1980;26/7:885-890.